One of the most remarkable aspects of Niche Science & Technology Ltd. is their commitment to staying at the forefront of advancements in science and technology. The team is known for its professionalism and reliability. They exhibit exceptional communication skills, ensuring that projects progress smoothly and efficiently. Many EVERSANA colleagues have worked with the NST team in the following areas and have always reported outstanding results:
"Having had the privilege of interacting with Niche Science & Technology Ltd. on various projects, I can attest to their unparalleled dedication to excellence, innovation, and integrity."
NST began work with EVERSANA in 2022, providing support guiding a late-stage development biotech company with an asset for Alzheimer’s disease. The company had expended considerable resources on delivery of their Phase II/III clinical programme. Their latest Phase III trial had followed a 15-month study in mild to moderate patients that showed no treatment benefits. Their latest trial was also apparently negative, possibly as a result of poor study design, and the company was trying to make sense of their data. The NST team devised regulatory strategy around interpretation of the opinion offered by the FDA and MHRA and future study designs. They also provided advice on the use of publicly available registry data to compare against their own data.
DemeRx is a US-based clinical stage pharmaceutical development company advancing drug candidates as therapies for.
read moreErytech Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, best known for its proprietary.
read moreFollowing the acquisition of Strimvelis and associated gene therapy assets by Orchard Therapeutics, our contributions.
read moreFunxional Therapeutics Ltd was a privately-held pharmaceutical start-up. It was set up in 2005 to commercialise the.
read moreHOOKIPA Pharma is a small but ambitious company with a pioneering vision for their arenavirus platform
read moreiOnctura is a clinical-stage biopharmaceutical company that benefited from our history with oncology indications, to.
read moreNanomerics’ mission is to deliver augmented medicines with improved activity and fewer associated side effects through.
read moreThromboserin Ltd. is an ‘innovator’ research company and our mission is to focus primarily on preventing arterial.
read moreVectivBio has evolved from a small biotech in engaged in early development into an organisation actively planning and.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
